Focus Partners Wealth boosted its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 57.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 366,812 shares of the financial services provider's stock after purchasing an additional 133,464 shares during the period. Focus Partners Wealth owned about 0.10% of CME Group worth $99,883,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CME. Asset Dedication LLC lifted its position in CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 37 shares during the period. FNY Investment Advisers LLC acquired a new position in shares of CME Group in the fourth quarter worth about $27,000. Hilton Head Capital Partners LLC acquired a new position in shares of CME Group in the fourth quarter worth about $28,000. Legacy Wealth Managment LLC ID raised its position in shares of CME Group by 191.9% in the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider's stock worth $29,000 after acquiring an additional 71 shares during the period. Finally, Global Wealth Strategies & Associates raised its position in shares of CME Group by 1,250.0% in the fourth quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider's stock worth $30,000 after acquiring an additional 100 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the sale, the insider directly owned 27,702 shares in the company, valued at $8,438,860.26. This represents a 17.20% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm's stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares in the company, valued at $16,606,111.30. The trade was a 38.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 44,044 shares of company stock worth $13,297,507 in the last ninety days. 0.30% of the stock is owned by corporate insiders.
Key Headlines Impacting CME Group
Here are the key news stories impacting CME Group this week:
Wall Street Analyst Weigh In
A number of brokerages have weighed in on CME. JPMorgan Chase & Co. boosted their target price on shares of CME Group from $266.00 to $271.00 and gave the stock an "underweight" rating in a research note on Thursday, April 16th. Deutsche Bank Aktiengesellschaft cut their target price on shares of CME Group from $342.00 to $322.00 and set a "buy" rating for the company in a research note on Thursday, April 23rd. Erste Group Bank cut shares of CME Group from a "buy" rating to a "hold" rating in a research note on Friday, June 5th. Wall Street Zen raised shares of CME Group from a "sell" rating to a "hold" rating in a research note on Saturday. Finally, Piper Sandler boosted their target price on shares of CME Group from $313.00 to $329.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 15th. Ten analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $305.71.
Read Our Latest Stock Analysis on CME
CME Group Stock Performance
CME Group stock opened at $269.53 on Monday. The firm has a 50 day simple moving average of $284.79 and a 200-day simple moving average of $288.16. CME Group Inc. has a 1-year low of $244.56 and a 1-year high of $329.16. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market cap of $97.67 billion, a price-to-earnings ratio of 23.00, a price-to-earnings-growth ratio of 3.01 and a beta of 0.21.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping the consensus estimate of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The firm had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same period in the prior year, the business posted $2.80 EPS. The business's revenue for the quarter was up 14.5% compared to the same quarter last year. On average, analysts expect that CME Group Inc. will post 12.28 EPS for the current year.
CME Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. CME Group's dividend payout ratio is 44.37%.
About CME Group
(
Free Report)
CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Stories
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.